Atypical clinical presentation associated with Castleman disease: a case report and review of the literature. [PDF]
Hu W, Kong Y, Hu B, Ai J, Zhang P.
europepmc +1 more source
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. [PDF]
Koga T +8 more
europepmc +1 more source
Clinical Utility of an Increased Pretreatment Immature Platelet Fraction in the Early Diagnosis of TAFRO Syndrome, Especially in Patients with Late-onset Thrombocytopenia: A Case Series and Literature Review. [PDF]
Saga T +3 more
europepmc +1 more source
Successful Treatment of Refractory TAFRO Syndrome with Cyclophosphamide: A Report of Two Cases. [PDF]
Nakamura K, Miki K, Ota S, Hoshi T.
europepmc +1 more source
Correction: TAFRO syndrome requiring combined IL 6 and IL 1 inhibition: a case report
Frontiers Production Office
doaj +1 more source
Diagnostic and therapeutic challenges in hyaline-vascular idiopathic multicentric Castleman disease: A case report. [PDF]
Lu C, Ma X, Liu B, Wang J, Luo S, Luo Q.
europepmc +1 more source
Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease. [PDF]
Ozaki T +8 more
europepmc +1 more source
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's Disease. [PDF]
Mumau MD +8 more
europepmc +1 more source
EXT1/EXT2-Associated Membranous Nephropathy Secondary to TAFRO Syndrome: A Case Report.
Kamido H +10 more
europepmc +1 more source

